Patent · US Active

αvβ6 peptide ligands and their uses

US8383593B2 · kind B2 · utility

6Cited by

0References

8Claims

0Family size

Assignee

Cancer Research Technology Limited · GB

Inventors

Mark J. Howard · Ashford, GB
Danielle Dicara · South San Francisco, US
John Marshall · London, GB

Key dates

Filing date	Oct 3, 2006
Grant date	Feb 26, 2013
Priority date	—
Expiry date	Aug 2, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

AVβ6 peptide ligands, functional variants thereof and their nucleic acids encoding them are disclosed with their uses in the treatment and imaging of AVβ6 mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.